|
|
| (28 intermediate revisions by the same user not shown) |
| Line 1: |
Line 1: |
| ==4. Final thoughts and additional resources== | | <div class="nonumtoc">__TOC__</div> |
| | {{ombox |
| | | type = notice |
| | | style = width: 960px; |
| | | text = This is sublevel35 of my sandbox, where I play with features and test MediaWiki code. If you wish to leave a comment for me, please see [[User_talk:Shawndouglas|my discussion page]] instead.<p></p> |
| | }} |
|
| |
|
| | | ==Sandbox begins below== |
| ===4.1 Final thoughts=== | |
| | |
| | |
| ===4.2 Key guidance documents===
| |
| | |
| * {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html |title=Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19) |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=24 March 2020}}
| |
| | |
| * {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html |title=Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19) |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=24 March 2020}}
| |
| | |
| * {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/lab/lab-biosafety-guidelines.html |title=Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19) |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=31 March 2020}}
| |
| | |
| * {{cite web |url=https://www.osha.gov/Publications/OSHA3990.pdf |format=PDF |title=Guidance on Preparing Workplaces for COVID-19 |work=OSHA 3990-03 2020 |author=Occupational Safety and Health Administration |publisher=Occupational Safety and Health Administration |date=March 2020}}
| |
| | |
| * {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-face-masks-and-respirators-during-coronavirus-disease-covid-19-public-health |title=Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency |work=FDA-2020-D-1138-0013 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=25 March 2020}}
| |
| | |
| * {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-gowns-other-apparel-and-gloves-during-coronavirus-disease-covid-19-public-health |title=Enforcement Policy for Gowns, Other Apparel, and Gloves During the Coronavirus Disease (COVID-19) Public Health Emergency |work=FDA-2020-D-1138-0023 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=30 March 2020}}
| |
| | |
| * {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-diagnostic-tests-coronavirus-disease-2019-during-public-health-emergency |title=Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency |work=FDA-2020-D-0987-0012 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=16 March 2020}}
| |
| | |
| * {{cite web |url=https://apps.who.int/iris/handle/10665/331500 |title=Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 19 March 2020 |work=WHO/WPE/GIH/2020.2 |author=World Health Organization, et al. |publisher=World Health Organization |date=19 March 2020}}
| |
| | |
| * {{cite web |url=https://apps.who.int/iris/handle/10665/331501 |title=Laboratory testing for coronavirus disease (COVID-19) in suspected human cases: Interim guidance, 19 March 2020 |work=WHO/COVID-19/laboratory/2020.5 |author=World Health Organization, et al. |publisher=World Health Organization |date=19 March 2020}}
| |
| | |
| ===4.3 Web portals===
| |
| | |
| * [https://www.cdc.gov/coronavirus/2019-ncov/hcp/index.html Coronavirus Disease 2019 (COVID-19) - Information for Healthcare Professionals] (CDC)
| |
| | |
| * [https://www.cdc.gov/coronavirus/2019-nCoV/lab/index.html Coronavirus Disease 2019 (COVID-19) - Information for Laboratories] (CDC)
| |
| | |
| * [https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-related-guidance-documents-industry-fda-staff-and-other-stakeholders COVID-19-Related Guidance Documents for Industry, FDA Staff, and Other Stakeholders] (FDA)
| |
| | |
| * [https://www.fema.gov/coronavirus Coronavirus (COVID-19) Response] (FEMA)
| |
| | |
| | |
| ====4.3.1. U.S. state-based resources and guidance portals====
| |
| | |
| * [https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/Guidance.aspx California]
| |
| * [https://www.health.state.mn.us/diseases/coronavirus/guidance.html Minnesota]
| |
| * [https://health.mo.gov/living/healthcondiseases/communicable/novel-coronavirus/ Missouri]
| |
| * [https://www.nh.gov/covid19/ New Hampshire]
| |
| * [https://coronavirus.health.ny.gov/home New York]
| |
| * [https://www.tn.gov/health/cedep/ncov.html Tennessee]
| |
| | |
| | |
| ===4.4 Key journal articles===
| |
| | |
| | |
| ===4.5 Public health lab directory===
| |
| | |
| | |
| ===4.6 National and global resources===
| |
| | |
| | |
| ===4.7 Public health laboratory informatics solutions===
| |
